@misc{10498/33591,
year = {2024},
url = {http://hdl.handle.net/10498/33591},
abstract = {Background Bipolar disorder (BD) is a severe psychiatric disorder characterized by changes in mood that alternate
between (hypo) mania or depression and mixed states, often associated with functional impairment and cognitive
dysfunction. But little is known about biomarkers that contribute to the development and sustainment of cognitive
defcits. The aim of this study was to review the association between neurocognition and biomarkers across diferent
mood states.
Method Search databases were Web of Science, Scopus and PubMed. A systematic review was carried out fol‑
lowing the PRISMA guidelines. Risk of bias was assessed with the Newcastle–Ottawa Scale. Studies were selected
that focused on the correlation between neuroimaging, physiological, genetic or peripheral biomarkers and cog‑
nition in at least two phases of BD: depression, (hypo)mania, euthymia or mixed. PROSPERO Registration No.:
CRD42023410782.
Results A total of 1824 references were screened, identifying 1023 published articles, of which 336 were considered
eligible. Only 16 provided information on the association between biomarkers and cognition in the diferent afective
states of BD. The included studies found: (i) Diferences in levels of total cholesterol and C reactive protein depending
on mood state; (ii) There is no association found between cognition and peripheral biomarkers; (iii) Neuroimaging
biomarkers highlighted hypoactivation of frontal areas as distinctive of acute state of BD; (iv) A deactivation failure
has been reported in the ventromedial prefrontal cortex (vmPFC), potentially serving as a trait marker of BD.
Conclusion Only a few recent articles have investigated biomarker-cognition associations in BD mood phases.
Our fndings underline that there appear to be central regions involved in BD that are observed in all mood states.
However, there appear to be underlying mechanisms of cognitive dysfunction that may vary across diferent mood
states in BD. This review highlights the importance of standardizing the data and the assessment of cognition, as well
as the need for biomarkers to help prevent acute symptomatic phases of the disease, and the associated functional
and cognitive impairment.},
publisher = {Springer},
keywords = {Biomarker},
keywords = {Bipolar disorder},
keywords = {Cognition},
keywords = {Mood state},
keywords = {Psychiatry},
title = {A systematic review of the biomarkers associated with cognition and mood state in bipolar disorder},
doi = {10.1186/S40345-024-00340-Z},
author = {Pérez-Ramos, A. and Romero López Alberca, Cristina and Hidalgo Figueroa, María and Berrocoso Domínguez, Esther María and Pérez Revuelta, José Ildefonso},
}